Switch to:
More From Other Websites
Galectin Therapeutics Announces Results From 12-Week Extension of Phase 2a Psoriasis Clinical Trial Aug 25 2016
Galectin Therapeutics Announces Results From 12-Week Extension of Phase 2a Psoriasis Clinical Trial Aug 25 2016
7:55 am Galectin Therapeutics announces interim results from an exploratory, open-label, Phase 2a... Aug 25 2016
GALECTIN THERAPEUTICS INC Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and... Aug 25 2016
GALECTIN THERAPEUTICS INC Financials Aug 17 2016
Galectin Therapeutics Reports Second Quarter 2016 Financial Results and Provides Business Update Aug 09 2016
Galectin Therapeutics Reports Second Quarter 2016 Financial Results and Provides Business Update Aug 09 2016
GALECTIN THERAPEUTICS INC Files SEC form 8-K, Results of Operations and Financial Condition,... Aug 09 2016
GALECTIN THERAPEUTICS INC Files SEC form 10-Q, Quarterly Report Aug 09 2016
Galectin Therapeutics Announces Completion of Patient Recruitment in its Phase 2 Trial with GR-MD-02... Aug 02 2016
Galectin Therapeutics Announces Completion of Patient Recruitment in its Phase 2 Trial with GR-MD-02... Aug 02 2016
GALECTIN THERAPEUTICS INC Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and... Aug 02 2016
Galectin Therapeutics (GALT) Jumps: Stock Rises 17.1% Aug 02 2016
Peter G. Traber, M.D., CEO and CMO of Galectin Therapeutics, to Speak on the Medical Applications of... Jul 13 2016
Peter G. Traber, M.D., CEO and CMO of Galectin Therapeutics, to Speak on the Medical Applications of... Jul 13 2016
Galectin Therapeutics Receives Notice of Australian Patent to be Granted for the Use of GR-MD-02 in... Jul 12 2016
Galectin Therapeutics Receives Notice of Australian Patent to be Granted for the Use of GR-MD-02 in... Jul 12 2016
Galectin Therapeutics Receives Notice of Australian Patent to be Granted for the Use of GR-MD-02 in... Jul 12 2016
GALECTIN THERAPEUTICS INC Files SEC form 8-K, Change in Directors or Principal Officers, Financial... Jun 20 2016
Galectin Therapeutics Announces Positive Preclinical Results on the Role of Galectin-3 in Mediating... Jun 02 2016


No Entry for this criteria! We are updating our databases daily, please come back later!

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK